Correlation Between Horizon Pharma and Bristol Myers
Can any of the company-specific risk be diversified away by investing in both Horizon Pharma and Bristol Myers at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Horizon Pharma and Bristol Myers into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Horizon Pharma PLC and Bristol Myers Squibb, you can compare the effects of market volatilities on Horizon Pharma and Bristol Myers and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Horizon Pharma with a short position of Bristol Myers. Check out your portfolio center. Please also check ongoing floating volatility patterns of Horizon Pharma and Bristol Myers.
Diversification Opportunities for Horizon Pharma and Bristol Myers
-0.6 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Horizon and Bristol is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Horizon Pharma PLC and Bristol Myers Squibb in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bristol Myers Squibb and Horizon Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Horizon Pharma PLC are associated (or correlated) with Bristol Myers. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bristol Myers Squibb has no effect on the direction of Horizon Pharma i.e., Horizon Pharma and Bristol Myers go up and down completely randomly.
Pair Corralation between Horizon Pharma and Bristol Myers
If you would invest 73,550 in Bristol Myers Squibb on September 16, 2024 and sell it today you would earn a total of 18,672 from holding Bristol Myers Squibb or generate 25.39% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 1.56% |
Values | Daily Returns |
Horizon Pharma PLC vs. Bristol Myers Squibb
Performance |
Timeline |
Horizon Pharma PLC |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Bristol Myers Squibb |
Horizon Pharma and Bristol Myers Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Horizon Pharma and Bristol Myers
The main advantage of trading using opposite Horizon Pharma and Bristol Myers positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Horizon Pharma position performs unexpectedly, Bristol Myers can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bristol Myers will offset losses from the drop in Bristol Myers' long position.Horizon Pharma vs. Bristol Myers Squibb | Horizon Pharma vs. AbbVie Inc | Horizon Pharma vs. Merck Company | Horizon Pharma vs. Gilead Sciences |
Bristol Myers vs. Novartis AG | Bristol Myers vs. Bayer AG | Bristol Myers vs. Astellas Pharma | Bristol Myers vs. Roche Holding AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |